Literature DB >> 11254901

Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats.

T Kobayashi1, K Kamata.   

Abstract

The hypothesis that the impaired endothelial function seen in streptozotocin (STZ)-induced diabetic rats may result from an increased nitric oxide (NO) metabolism was tested. Acetylcholine (ACh) increased the nitrite NO(2-) and nitrate (NO(3-)) levels in the perfusates from both control and diabetic aortic strips, although the level of NO(2-) was significantly lower in diabetic rats while the NO(3-) level was significantly higher. Both effects (decrease in NO(2-) and increase in NO(3-)) were ameliorated by chronic administration of insulin to diabetic rats but NOx (NO(2-) plus NO(3-)) was increased. The expression of endothelial nitric oxide synthase (eNOS) was significantly increased by chronic administration of insulin to diabetic rats. A decrease in NO(2-) and an increase in NO(3-) occurred following treatment of control aortae with hypoxanthine/xanthine oxidase. Incubating diabetic aortic strips with superoxide dismutase (SOD) normalized the production of both NO(2-) and NO(3-). Both the basal and the ACh-stimulated production of O(2)(-) were significantly higher in diabetic rats than in controls. These results demonstrate that the ACh-induced relaxation of aortic strips was significantly impaired in diabetic rats and that this impairment may be due to an abnormal oxidative metabolism of NO, rather than to a decrease in NOS mRNA and NO production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254901     DOI: 10.1016/s0021-9150(00)00583-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products.

Authors:  Malarvannan Pannirselvam; William B Wiehler; Todd Anderson; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

2.  Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats.

Authors:  Zs Soltész; T Tábi; A S Halász; M Pálfi; E Kocsis; K Magyar; M Tóth; E Szökö
Journal:  J Neural Transm (Vienna)       Date:  2007-04-13       Impact factor: 3.575

3.  Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat.

Authors:  Noriyasu Kanie; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

4.  Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.

Authors:  Leryn J Reynolds; Daniel P Credeur; Camila Manrique; Jaume Padilla; Paul J Fadel; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2016-10-27

5.  Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans.

Authors:  K A Han; Y Patel; A A Lteif; R Chisholm; Kieren J Mather
Journal:  Diabetes Metab Res Rev       Date:  2011-05       Impact factor: 4.876

6.  Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse.

Authors:  Hong Ding; Michael Hashem; William B Wiehler; Winnie Lau; Jacqueline Martin; Julianne Reid; Chris Triggle
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

7.  Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats.

Authors:  Noriyasu Kanie; Takayuki Matsumoto; Tsuneo Kobayashi; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

8.  Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.

Authors:  T Kobayashi; T Nogami; K Taguchi; T Matsumoto; K Kamata
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

9.  Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment.

Authors:  Cimen Karasu
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

10.  Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats.

Authors:  Murat Olukman; Ebru Demirel Sezer; Sibel Ulker; Eser Y Sözmen; Gülcihan Mehtap Cınar
Journal:  Exp Diabetes Res       Date:  2010-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.